Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

187 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.
Frazão JM, Elangovan L, Maung HM, Chesney RW, Acchiardo SR, Bower JD, Kelley BJ, Rodriguez HJ, Norris KC, Robertson JA, Levine BS, Goodman WG, Gentile D, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW. Frazão JM, et al. Among authors: mazess rb. Am J Kidney Dis. 2000 Sep;36(3):550-61. doi: 10.1053/ajkd.2000.16193. Am J Kidney Dis. 2000. PMID: 10977787 Clinical Trial.
1 alpha-Hydroxy-vitamin D2: a new look at an 'old' compound.
Coburn JW, Tan AU Jr, Levine BS, Mazess RB, Kyllo DM, Knutson JC, Bishop CW. Coburn JW, et al. Among authors: mazess rb. Nephrol Dial Transplant. 1996;11 Suppl 3:153-7. doi: 10.1093/ndt/11.supp3.153. Nephrol Dial Transplant. 1996. PMID: 8840332 Review.
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.
Maung HM, Elangovan L, Frazão JM, Bower JD, Kelley BJ, Acchiardo SR, Rodriguez HJ, Norris KC, Sigala JF, Rutkowski M, Robertson JA, Goodman WG, Levine BS, Chesney RW, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW. Maung HM, et al. Among authors: mazess rb. Am J Kidney Dis. 2001 Mar;37(3):532-43. Am J Kidney Dis. 2001. PMID: 11228177 Clinical Trial.
187 results